Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): Case reports from a tertiary care hospital in Saudi Arabia

Annals of Saudi Medicine

Volumn 34, Issue 5, 2014, Pages 396-400

  Khalid, Mohammad ^a   Khan, Basha ^a   Al Rabiah, Fahad ^a   Alismaili, Ruwaida ^a   Saleemi, Sarfraz ^a   Rehan Khaliq, Agha Muhammad ^a   Weheba, Ihab ^a   Al Abdely, Hail ^a   Halim, Magid ^a   Nadri, Quaid Johar ^a   Al Dalaan, Abdullah Mohsin ^a   Zeitouni, Mohamed ^a   Butt, Taimur ^a   Al Mutairy, Eid ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2B; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORONAVIRIDAE INFECTION; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG INFILTRATE; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; OPEN READING FRAME; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAUDI ARABIA; SPUTUM; TERTIARY CARE CENTER; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY ELDERLY; ASYMPTOMATIC INFECTION; CORONAVIRUS INFECTIONS; DELAYED DIAGNOSIS; DRUG COMBINATION; EPIDEMIOLOGY; TIME TO TREATMENT; VIROLOGY;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; ASYMPTOMATIC INFECTIONS; CORONAVIRUS INFECTIONS; DELAYED DIAGNOSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RESPIRATORY INSUFFICIENCY; RIBAVIRIN; SAUDI ARABIA; TERTIARY CARE CENTERS; TIME-TO-TREATMENT;

EID: 84929337072     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2014.396     Document Type: Article

References (15)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-1820.
2. Ministry of Health [webpage on the Internet]. Statistics and daily reports. Kingdom of Saudi Arabia: Ministry of Health; 2014. Available from: http://www.moh.gov.sa/en/ccc/PressReleases/Pages/default.aspx. Accessed July 15, 2014.
3. Ministry of Health. Case Definition and Surveillance Guidance for MERS-CoV Testing in Saudi Arabia. Saudi Arabia: Ministry of Health; 2014. Available from. http://www.moh.gov.sa/en/Documents/MoHCaseDefinitionMERSCoVVersion-May132014.pdf. Accessed May 13, 2014.
4. Falzarano D, de Wit E, Martellaro C, et al. Inhibition of novel ? coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 2013; 3:1686.
5. Khan K, Sears J, Hu VW, et al. Potential for the international spread of middle East respiratory syndrome in association with mass gatherings in Saudi Arabia. PLoS Curr. 2013;5.
6. Alagaili AN, Briese T, Mishra N, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014;5(2):e00884-14.
7. Saey TH. Camels implicated as possible hosts of MERS virus. Science News. Online available from https://www.sciencenews.org/article/camelsimplicated-possible-hosts-mers-virus. Accessed August 8, 2013.
8. Briese T, Mishra N, Jain K, et al. 2014. Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia. MBio. 2014;5(3):e01146-14.
9. Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014;370(26): 2499-2505.
10. Falzarano D, de Wit E, Rasmussen AL, et al. Treatment with interferon-?2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013;19(10):1313-1317.
11. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42-46.
12. a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14(11):1090-1095.
13. Guery B, van der Werf S. Coronavirus: need for a therapeutic approach. Lancet Infect Dis. 2013;13(9):726-727.
14. Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H. Inhibition of novel ? coronavirus replication by a combination of interferon-?2b and ribavirin. Sci Rep. 2013;3:1686.
15. Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis. 2013;17(10):e792-e798.